Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure

Tomoyasu Jo, Yasuyuki Arai, Satoshi Yoshihara, Minoru Kojima, Junko Ikemoto, Tomoe Uemura, Keita Iwaki, Noboru Yonetani, Shin-ichiro Fujiwara, Masaki Ri, Kaoru Kahata, Tokiko Nagamura-Inoue, Minami Yamada-Fujiwara, Ryuji Tanosaki

Blood (2022) 140 (Supplement 1): 1608–1609.

https://doi.org/10.1182/blood-2022-165613

Published: 2022

Journal Articles

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 2633–2634.

https://doi.org/10.1182/blood-2022-162172

Published: 2022

Journal Articles

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Satoshi Yoshioka, MD, PhD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2198.

https://doi.org/10.1182/blood.V128.22.2198.2198

Published: 2016

Journal Articles

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Daisuke Kato, MD, Satoshi Yoshioka, MD, PhD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2966.

https://doi.org/10.1182/blood.V128.22.2966.2966

Published: 2016

Journal Articles

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1463.

https://doi.org/10.1182/blood.V126.23.1463.1463

Published: 2015

Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1480.

https://doi.org/10.1182/blood.V126.23.1480.1480

Published: 2015

Journal Articles

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Yoshimitsu Shimomura, MD, Hayato Maruoka, M.T, Yotaro Ochi, MD, Yusuke Koba, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 3207.

https://doi.org/10.1182/blood.V126.23.3207.3207

Published: 2015

Journal Articles

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

June Takeda, MD, Hiroshi Kawabata, MD, PhD, Kazunari Aoki, MD, Shuichi Shiga, S.H., Masahiro Kawahara, MD PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiyuki Kitano, MD, Noboru Yonetani, MD, Sumie Tabata, MD, PhD, Nobuhiro Hiramoto, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, Norimitsu Kadowaki, MD PhD, Akifumi Takaori, MD, PhD

Blood (2014) 124 (21): 1907.

https://doi.org/10.1182/blood.V124.21.1907.1907

Published: 2014

Journal Articles

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Yasuhiro Kazuma, MD, Kazunari Aoki, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yosuke Nagahata, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 3030.

https://doi.org/10.1182/blood.V124.21.3030.3030

Published: 2014

Journal Articles

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2962.

https://doi.org/10.1182/blood.V124.21.2962.2962

Published: 2014

Journal Articles

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

Yotaro Ochi, MD, Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Megumu Hino, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 1647.

https://doi.org/10.1182/blood.V124.21.1647.1647

Published: 2014

Journal Articles

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Yosuke Nagahata, MD, Yoshimitsu Shimomura, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2298.

https://doi.org/10.1182/blood.V124.21.2298.2298

Published: 2014

Journal Articles

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Yuichiro Ono, M.D., June Takeda, M.D., Hayato Maruoka, Yasuhiro Kazuma, M.D., Nobuhiro Hiramoto, MD, Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yuki Funayama, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Koji Nasu, Takayuki Takahashi, M.D., Ph.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3921.

https://doi.org/10.1182/blood.V122.21.3921.3921

Published: 2013

Journal Articles

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

June Takeda, M.D., Nobuhiko Yamauchi, M.D., Kazunari Aoki, MD, Yuichiro Ono, M.D., Yuki Funayama, M.D., Yasuhiro Kazuma, M.D., Yosuke Nagahata, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Nobuhiro Hiramoto, M.D., Akiko Matsushita, M.D., Noboru Yonetani, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 5215.

https://doi.org/10.1182/blood.V122.21.5215.5215

Published: 2013

Journal Articles

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Yosuke Nagahata, M.D., Yuichiro Ono, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Nobuhiko Yamauchi, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 2166.

https://doi.org/10.1182/blood.V122.21.2166.2166

Published: 2013

Journal Articles

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Yuichiro Ono, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3008.

https://doi.org/10.1182/blood.V122.21.3008.3008

Published: 2013

Journal Articles

Prognostic Impact of Serum Soluble Interleukin-2 Receptor Values Just After Completion of R-CHOP in Diffuse Large B-Cell Lymphoma

Nobuhiko Yamauchi, MD, Kazunari Aoki, MD, June Takeda, MD, Yuki Funayama, M.D., Aiko Kato, M.D., Yuichiro Ono, M.D., Sumie Tabata, MD, PhD, Akiko Matsushita, MD, Noboru Yonetani, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2012) 120 (21): 1591.

https://doi.org/10.1182/blood.V120.21.1591.1591

Published: 2012

Journal Articles

International Prognostic Index, Serum IgA Level, and Monocytes Count Are Independently Associated with Overall Survival in Patients with HTLV-I-Negative Nodal Peripheral T-Cell Lymphoma

Aiko Kato, M.D., Yukihiro Imai, MD, PhD, June Takeda, MD, Nobuhiko Yamauchi, MD, Yuki Funayama, M.D., Kazunari Aoki, MD, Yuichiro Ono, M.D., Sumie Tabata, MD, PhD, Noboru Yonetani, MD, PhD, Akiko Matsushita, MD, Takayuki Ishikawa, M.D., Ph.D.

Blood (2012) 120 (21): 1577.

https://doi.org/10.1182/blood.V120.21.1577.1577

Published: 2012

NARROW

Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Prognostic Impact of Serum Soluble Interleukin-2 Receptor Values Just After Completion of R-CHOP in Diffuse Large B-Cell Lymphoma

International Prognostic Index, Serum IgA Level, and Monocytes Count Are Independently Associated with Overall Survival in Patients with HTLV-I-Negative Nodal Peripheral T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only